Literature DB >> 22504863

Management of severe neuropathic cancer pain: an illustrative case and review.

Irene Connolly1, Carolyn Zaleon, Marcos Montagnini.   

Abstract

Neuropathic cancer pain is common, very disabling and difficult to treat. It can be related to tumor invasion of neural structures and neuronal damage by surgery, chemotherapy and radiation therapy. Adjuvant analgesics are often used with opioids to control neuropathic pain in cancer patients. Methadone, a synthetic opioid with multiple mechanisms of action, is gaining increasing importance as an effective agent in the treatment of cancer related neuropathic pain. This case illustrates the challenges of managing severe pain in a patient with head and neck cancer while undergoing anti-tumor treatment. A review of the adjuvant analgesics and opioids, particularly methadone, in the management of neuropathic pain is also included.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22504863     DOI: 10.1177/1049909112443586

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  5 in total

1.  Sciatic nerve transection modulates oxidative parameters in spinal and supraspinal regions.

Authors:  Taína Scheid; Lidiane Dal Bosco; Renata P Guedes; Maria Amália Pavanato; Adriane Belló-Klein; Wania A Partata
Journal:  Neurochem Res       Date:  2013-02-20       Impact factor: 3.996

Review 2.  Cancer and Referred Facial Pain.

Authors:  Marcela Romero-Reyes; Antonia Teruel; Yi Ye
Journal:  Curr Pain Headache Rep       Date:  2015-08

3.  Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit.

Authors:  Gabriela P Peirano; Guillermo P Mammana; Mariela S Bertolino; Tania Pastrana; Gloria F Vega; Jorgelina Russo; Gabriela Varela; Ernesto Vignaroli; Raúl Ruggiero; Arnaldo Armesto; Gabriela Camerano; Graciela Dran
Journal:  Support Care Cancer       Date:  2016-03-29       Impact factor: 3.603

Review 4.  Neuropathic cancer pain: What we are dealing with? How to manage it?

Authors:  Ece Esin; Suayib Yalcin
Journal:  Onco Targets Ther       Date:  2014-04-17       Impact factor: 4.147

Review 5.  Cancer and orofacial pain.

Authors:  M Romero-Reyes; D Salvemini
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.